These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 23545756

  • 1. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW, Vondracek TG.
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [Abstract] [Full Text] [Related]

  • 2. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE, Zumberg MS.
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [Abstract] [Full Text] [Related]

  • 3. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
    Vandiver JW, Vondracek TG.
    Pharmacotherapy; 2012 Jun; 32(6):546-58. PubMed ID: 22531940
    [Abstract] [Full Text] [Related]

  • 4. Comparison of unfractionated heparin protocols using antifactor Xa monitoring or activated partial thrombin time monitoring.
    Frugé KS, Lee YR.
    Am J Health Syst Pharm; 2015 Sep 01; 72(17 Suppl 2):S90-7. PubMed ID: 26272899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M.
    Arch Intern Med; 1994 Jan 10; 154(1):49-56. PubMed ID: 8267489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, Galashan D, Oskamp ML, Brennan B, Ginsberg JS.
    Thromb Haemost; 2002 Jan 10; 87(1):92-7. PubMed ID: 11848463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The PiCT® test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study.
    Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W.
    J Thromb Haemost; 2016 Nov 10; 14(11):2187-2193. PubMed ID: 27582411
    [Abstract] [Full Text] [Related]

  • 11. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D, Långström S, Petäjä J, Heikinheimo M, Pihkala J.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1174-9. PubMed ID: 22915548
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.
    Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Lau A, Mitchell LG.
    Haematologica; 2007 Apr 01; 92(4):554-7. PubMed ID: 17488668
    [Abstract] [Full Text] [Related]

  • 14. Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.
    Clark NP, Delate T, Cleary SJ, Witt DM.
    Thromb Res; 2010 May 01; 125(5):402-5. PubMed ID: 19699510
    [Abstract] [Full Text] [Related]

  • 15. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.
    Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T.
    Am J Clin Pathol; 2013 Apr 01; 139(4):450-6. PubMed ID: 23525615
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin.
    Wahking RA, Hargreaves RH, Lockwood SM, Haskell SK, Davis KW.
    Ann Pharmacother; 2019 Aug 01; 53(8):801-805. PubMed ID: 30813751
    [Abstract] [Full Text] [Related]

  • 19. A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin.
    Belk KW, Laposata M, Craver C.
    J Thromb Haemost; 2016 Nov 01; 14(11):2148-2157. PubMed ID: 27543785
    [Abstract] [Full Text] [Related]

  • 20. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.
    Oladunjoye OO, Sleeper LA, Nair AG, Trenor CC, VanderPluym C, Kheir JN, Emani SM.
    J Thorac Cardiovasc Surg; 2018 Jul 01; 156(1):332-340.e1. PubMed ID: 29709361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.